Project Grant R01AR083979

Award Date 6/15/25
Completion Date 5/31/30
Dollars Obligated $499K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The federal Project Grant award K99AR084574, funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to identify the molecular and cellular mechanisms controlling tendon cell activation and regeneration after injury to the tendon-bone attachment, or enthesis. With a total funding amount of $317,211.00 awarded on July 5, 2024 and an ultimate completion date of June 30,...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846), is providing $359,133 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to generate new genetic tools for advancing tendon and musculoskeletal research. The grant aims to develop constitutive and inducible FLP alleles that can be used with...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, provides $158,912 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to investigate the role of Wnt signaling in the mechanical maturation of tendons. The project aims to elucidate the function of Wnt signaling in postnatal tendon maturation and explore if mechanical cues...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $501,450 to The Washington University to conduct research on regulating tendon repair using stem cell-derived extracellular vesicles. The study aims to identify the specific subpopulation and active cargo molecules of extracellular vesicles that can enhance tendon healing and avoid...
This federal Project Grant award in the amount of $1,043,049.02 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award will support research at the University of Rochester focused on understanding the role of epitenon-derived progenitor cells in tendon healing and adaptation. The proposed studies will use advanced genetic lineage tracing and single-cell...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846), will provide $570,878 to the University of Rochester to fund research on modulating myofibroblast dynamics during tendon healing. The goal is to define the efficacy of pharmacological activation of the GPR68 receptor to regulate the differentiation and reversion of tenocytes to...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $201,960 to the University of Vermont & State Agricultural College to develop a novel zebrafish model system for studying the functional impact of different myosin-binding protein C (MyBP-C) isoforms on muscle contractility. The research aims to generate "designer"...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $621,703.00 to Cornell University to conduct research focused on promoting a reparative rather than degenerative outcome from loading of fatigue-damaged tendons. The research aims to investigate the mechanisms by which glycosaminoglycans, specifically hyaluronan and dermatan sulfate,...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $270,000 to support research focused on understanding the mechanisms underlying spinal cord regeneration in zebrafish. The goal is to elucidate the key cellular and molecular processes that enable zebrafish to spontaneously regenerate spinal cord connections after injury, in contrast to the limited...
This $153,548 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) supports research to determine the cellular and molecular mechanisms that enable highly regenerative mammalian species, such as spiny mice and rabbits, to maintain cell proliferation and regenerate complex skin and musculoskeletal tissues. The objective is to leverage insights from these unique...

The project grant award R01AR083979, titled "Mechanisms Underlying Adult Tendon Regeneration in the Zebrafish", is funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The $499,229 award supports research to investigate the role of TGFβ signaling and muscle activity in adult tendon regeneration using the zebrafish model. The project aims to examine how reduced TGFβ signaling and muscle activity affect cellular composition and fate during tendon regeneration, test the temporal and spatial regulation of TGFβ signaling in tendon regeneration, and identify new pathways differentially regulated in regenerative versus non-regenerative contexts. The research is being conducted by the General Hospital Corporation, doing business as Massachusetts General Hospital, from June 2025 to May 2030.

Generated 6/24/25, 5:26 AM